Meena Alnajar is an IPilogue Senior Editor, an IP Innovation Clinic Senior Fellow, and a 3L JD Candidate at Osgoode Hall Law School. This article was written as a requirement…
Tag: pharmaceuticals
United States Bill S. 4734: Should Diagnostic Tests be Eligible for Patent Protection
Serena Nath is an IPilogue Writer and a 2L JD candidate at Osgoode Hall Law School. Controversy and uncertainty in the field of patent eligibility have resulted in decade-long fights…
The Role of Patents: A Competition Sword or Shield
Andrew Masson is an IPilogue Writer and 2L JD candidate at Osgoode Hall Law School. A business’ success is strongly tied to the ability to protect Intellectual Property. However, the USA…
Gilead and ViiV Healthcare Settle Global Patent Dispute for Over $1B USD
Brandon Pierre is an IPilogue Writer and a 1L JD Candidate at Osgoode Hall Law School. In a dizzying exception to an exception of a rule, the case of…
The Final Countdown? The Upcoming Changes to the Patented Medicines Regulations
Jasmine Yu is an IPilogue Writer and a 1L JD Candidate at the University of Toronto. After numerous delays over two years, amendments to the Patented Medicines Regulations, which governs Canada’s Patented…
The Competition Bureau And Health Canada Issue Joint Notice On Continued Collaboration In Pharmaceutical Sector
M. Imtiaz Karamat is an IP Osgoode Alumnus and Associate Lawyer at Deeth Williams Wall LLP. This article was originally posted on E-TIPS™ For Deeth Williams Wall LLP on January 26,…